Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development
- PMID: 25283275
- DOI: 10.1002/dvg.22829
Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen development
Abstract
The spleen is a lymphoid organ that serves as a unique niche for immune reactions, extramedullary hematopoiesis, and the removal of aged erythrocytes from the circulation. While much is known about the immunological functions of the spleen, the mechanisms governing the development and organization of its stromal microenvironment remain poorly understood. Here we report the generation and analysis of a Tlx1(Cre) (ER) (-Venus) knock-in mouse strain engineered to simultaneously express tamoxifen-inducible CreER(T2) and Venus fluorescent protein under the control of regulatory elements of the Tlx1 gene, which encodes a transcription factor essential for spleen development. We demonstrated that Venus as well as CreER expression recapitulates endogenous Tlx1 transcription within the spleen microenvironment. When Tlx1(Cre) (ER) (-Venus) mice were crossed with the Cre-inducible reporter strain, Tlx1-expressing cells as well as their descendants were specifically labeled following tamoxifen administration. We also showed by cell lineage tracing that asplenia caused by Tlx1 deficiency is attributable to altered contribution of mesenchymal cells in the spleen anlage to the pancreatic mesenchyme. Thus, Tlx1(Cre) (ER) (-Venus) mice represent a new tool for lineage tracing and conditional gene manipulation of spleen mesenchymal cells, essential approaches for understanding the molecular mechanisms of spleen development.
Keywords: Tlx1; Venus; lineage tracing; mouse; spleen; tamoxifen-inducible Cre.
© 2014 Wiley Periodicals, Inc.
Similar articles
-
Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1.Sci Rep. 2018 May 29;8(1):8308. doi: 10.1038/s41598-018-26693-x. Sci Rep. 2018. PMID: 29844356 Free PMC article.
-
Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9.Genesis. 2016 Sep;54(9):490-6. doi: 10.1002/dvg.22956. Epub 2016 Jul 26. Genesis. 2016. PMID: 27381449 Free PMC article.
-
Generation and characterization of a tamoxifen inducible Msx1(CreERT2) knock-in allele.Genesis. 2013 Feb;51(2):110-9. doi: 10.1002/dvg.22350. Epub 2012 Dec 20. Genesis. 2013. PMID: 23090744
-
The promise of Hox11+ stem cells of the spleen for treating autoimmune diseases.Horm Metab Res. 2008 Feb;40(2):137-46. doi: 10.1055/s-2007-1022560. Horm Metab Res. 2008. PMID: 18283632 Review.
-
Ocular surface tissue morphogenesis in normal and disease states revealed by genetically modified mice.Cornea. 2006 Dec;25(10 Suppl 1):S7-S19. doi: 10.1097/01.ico.0000247207.55520.a4. Cornea. 2006. PMID: 17001198 Review.
Cited by
-
Transcription factor Tlx1 marks a subset of lymphoid tissue organizer-like mesenchymal progenitor cells in the neonatal spleen.Sci Rep. 2019 Dec 31;9(1):20408. doi: 10.1038/s41598-019-56984-w. Sci Rep. 2019. PMID: 31892733 Free PMC article.
-
Niche-induced extramedullary hematopoiesis in the spleen is regulated by the transcription factor Tlx1.Sci Rep. 2018 May 29;8(1):8308. doi: 10.1038/s41598-018-26693-x. Sci Rep. 2018. PMID: 29844356 Free PMC article.
-
Stromal Cell Subsets Directing Neonatal Spleen Regeneration.Sci Rep. 2017 Jan 9;7:40401. doi: 10.1038/srep40401. Sci Rep. 2017. PMID: 28067323 Free PMC article.
-
Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.Onco Targets Ther. 2020 Mar 24;13:2483-2490. doi: 10.2147/OTT.S232965. eCollection 2020. Onco Targets Ther. 2020. PMID: 32273720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials